Alessandra Frezzolini

Summary

Affiliation: Istituto Dermopatico dell'Immacolata
Country: Italy

Publications

  1. ncbi request reprint Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid
    Alessandra Frezzolini
    Department of Immunodermatology, Istituto Dermopatico dell Immacolata, IDI, IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy
    Eur J Dermatol 12:27-31. 2002
  2. pmc Interleukin-16 expression and release in bullous pemphigoid
    A Frezzolini
    Laboratory of Immunology and Allergology, Istituto Dermopatico dell Immacolata, IDI IRCCS, Rome, Italy
    Clin Exp Immunol 137:595-600. 2004
  3. doi request reprint Usefulness of the CD63 basophil activation test in detecting Anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up
    A Frezzolini
    Laboratory of Immunology and Allergology, Istituto Dermopatico dell Immacolata, Rome, Italy
    Clin Exp Dermatol 35:765-70. 2010
  4. ncbi request reprint Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications
    Paolo Amerio
    Department of Immunodermatology and Allergology, Istituto Dermopatico dell Immacolata IRCCS, Rome, Italy
    Curr Drug Targets Inflamm Allergy 2:81-94. 2003
  5. ncbi request reprint Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature
    Giuseppe Cianchini
    Division of Dermatology, Istituto Dermopatico dell Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy
    Arch Dermatol 143:1033-8. 2007
  6. doi request reprint The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris
    Anna Sinistro
    Molecular and Cell Biology Laboratory, Istituto Dermopatico dell Immacolata IDI IRCCS, 00167 Rome, Italy
    Eur J Dermatol 25:578-85. 2015
  7. doi request reprint Usefulness of skin immunofluorescence for distinguishing SLE from SLE-like renal lesions: a pilot study
    Ines L'Erario
    Department of Nephrology and Urology, Division of Nephrology and Dialysis, Bambino Gesu Children s Hospital and Research Institute, Rome, Italy
    Pediatr Nephrol 26:77-83. 2011
  8. ncbi request reprint Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group
    Pietro Quaglino
    Department of Biomedical Sciences and Human Oncology, Section of Dermatology, 1st Dermatologic Clinic, University of Turin, Turin, Italy
    Dermatology 214:296-304. 2007

Collaborators

Detail Information

Publications8

  1. ncbi request reprint Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid
    Alessandra Frezzolini
    Department of Immunodermatology, Istituto Dermopatico dell Immacolata, IDI, IRCCS, Via dei Monti di Creta, 104, 00167 Rome, Italy
    Eur J Dermatol 12:27-31. 2002
    ....
  2. pmc Interleukin-16 expression and release in bullous pemphigoid
    A Frezzolini
    Laboratory of Immunology and Allergology, Istituto Dermopatico dell Immacolata, IDI IRCCS, Rome, Italy
    Clin Exp Immunol 137:595-600. 2004
    ....
  3. doi request reprint Usefulness of the CD63 basophil activation test in detecting Anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up
    A Frezzolini
    Laboratory of Immunology and Allergology, Istituto Dermopatico dell Immacolata, Rome, Italy
    Clin Exp Dermatol 35:765-70. 2010
    ..The basophil activation test (BAT) has been recently described as a useful in vitro tool for diagnosis of allergy to Anisakis species in patients with acute urticaria...
  4. ncbi request reprint Eotaxins and CCR3 receptor in inflammatory and allergic skin diseases: therapeutical implications
    Paolo Amerio
    Department of Immunodermatology and Allergology, Istituto Dermopatico dell Immacolata IRCCS, Rome, Italy
    Curr Drug Targets Inflamm Allergy 2:81-94. 2003
    ....
  5. ncbi request reprint Treatment of severe pemphigus with rituximab: report of 12 cases and a review of the literature
    Giuseppe Cianchini
    Division of Dermatology, Istituto Dermopatico dell Immacolata, IRCCS, Via dei Monti di Creta 104, 00167 Rome, Italy
    Arch Dermatol 143:1033-8. 2007
    ..We report 10 cases of pemphigus vulgaris and 2 cases of pemphigus foliaceous treated with rituximab--to our knowledge the largest series of patients so far--and review the existing literature on the topic...
  6. doi request reprint The pathogenic activity of anti-desmoglein autoantibodies parallels disease severity in rituximab-treated patients with pemphigus vulgaris
    Anna Sinistro
    Molecular and Cell Biology Laboratory, Istituto Dermopatico dell Immacolata IDI IRCCS, 00167 Rome, Italy
    Eur J Dermatol 25:578-85. 2015
    ..Our findings have demonstrated the existence of non-pathogenic autoantibodies in PV patients in remission, establishing the basis for the design of a system able to precisely monitor the course of disease. ..
  7. doi request reprint Usefulness of skin immunofluorescence for distinguishing SLE from SLE-like renal lesions: a pilot study
    Ines L'Erario
    Department of Nephrology and Urology, Division of Nephrology and Dialysis, Bambino Gesu Children s Hospital and Research Institute, Rome, Italy
    Pediatr Nephrol 26:77-83. 2011
    ..In addition, they identify an intermediate group of patients with evidence of systemic involvement despite the absence of a sufficient number of ARA criteria to be labeled as SLE...
  8. ncbi request reprint Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group
    Pietro Quaglino
    Department of Biomedical Sciences and Human Oncology, Section of Dermatology, 1st Dermatologic Clinic, University of Turin, Turin, Italy
    Dermatology 214:296-304. 2007
    ..No data exist as to Th2 chemokines in erythema multiforme (EM) and Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN)...